RAB1A and prostate cancer: Rab1A has been identified as a colorectal oncogene, and elevated expression of Rab1A has been reported in multiple cancer types, including colorectal cancer (CRC) [8], hepatocellular carcinoma (HCC) [18], glioma [14], prostate cancer [15, 17], tongue squamous carcinoma [16] and cervical cancer [19].